These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 33524147)

  • 1. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
    Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary thyroid cancer organoids harboring BRAF
    Chen D; Su X; Zhu L; Jia H; Han B; Chen H; Liang Q; Hu C; Yang H; Liu L; Li P; Wei W; Zhao Y
    J Transl Med; 2023 Jan; 21(1):9. PubMed ID: 36624452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of papillary thyroid cancer organoid lines from clinical specimens.
    Yang H; Liang Q; Zhang J; Liu J; Wei H; Chen H; Wei W; Chen D; Zhao Y
    Front Endocrinol (Lausanne); 2023; 14():1140888. PubMed ID: 36992805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
    Broutier L; Mastrogiovanni G; Verstegen MM; Francies HE; Gavarró LM; Bradshaw CR; Allen GE; Arnes-Benito R; Sidorova O; Gaspersz MP; Georgakopoulos N; Koo BK; Dietmann S; Davies SE; Praseedom RK; Lieshout R; IJzermans JNM; Wigmore SJ; Saeb-Parsy K; Garnett MJ; van der Laan LJ; Huch M
    Nat Med; 2017 Dec; 23(12):1424-1435. PubMed ID: 29131160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
    Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Sensitivity Assays of Human Cancer Organoid Cultures.
    Francies HE; Barthorpe A; McLaren-Douglas A; Barendt WJ; Garnett MJ
    Methods Mol Biol; 2019; 1576():339-351. PubMed ID: 27628132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
    Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
    Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PES1 promotes the occurrence and development of papillary thyroid cancer by upregulating the ERα/ERβ protein ratio.
    Qiu YB; Liao LY; Jiang R; Xu M; Xu LW; Chen GG; Liu ZM
    Sci Rep; 2019 Jan; 9(1):1032. PubMed ID: 30705367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor α induces prosurvival autophagy in papillary thyroid cancer via stimulating reactive oxygen species and extracellular signal regulated kinases.
    Fan D; Liu SY; van Hasselt CA; Vlantis AC; Ng EK; Zhang H; Dong Y; Ng SK; Chu R; Chan AB; Du J; Wei W; Liu X; Liu Z; Xing M; Chen GG
    J Clin Endocrinol Metab; 2015 Apr; 100(4):E561-71. PubMed ID: 25594859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression.
    Hosseinkhan N; Honardoost M; Blighe K; Moore CBT; Khamseh ME
    J Endocrinol Invest; 2020 Jul; 43(7):911-923. PubMed ID: 31965517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
    Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
    Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma.
    Li M; Chai HF; Peng F; Meng YT; Zhang LZ; Zhang L; Zou H; Liang QL; Li MM; Mao KG; Sun DX; Tong MY; Deng ZQ; Hou ZJ; Zhao Y; Li J; Wang XC; Lv SS; Zhang QQ; Yu X; Lam EW; Liu Q; Cui XN; Xu J
    Cell Death Dis; 2018 Nov; 9(11):1120. PubMed ID: 30389909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
    Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS
    Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
    Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
    Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
    Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic heterogeneity of 2D organoid reflects clinical tumor characteristics.
    Fujino S; Ito A; Ohue M; Yasui M; Mizushima T; Doki Y; Mori M; Miyoshi N
    Biochem Biophys Res Commun; 2019 May; 513(2):332-339. PubMed ID: 30955861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations.
    Jabs J; Zickgraf FM; Park J; Wagner S; Jiang X; Jechow K; Kleinheinz K; Toprak UH; Schneider MA; Meister M; Spaich S; Sütterlin M; Schlesner M; Trumpp A; Sprick M; Eils R; Conrad C
    Mol Syst Biol; 2017 Nov; 13(11):955. PubMed ID: 29180611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
    Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
    Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of the RSK4 promoter associated with BRAF V600E promotes papillary thyroid carcinoma.
    Yin Y; Che K; Hu J; Hua H; Dong A; Wang J; Yu J; Zhang Q; Zhao S; Zhao Y; Wang P; Wang F; Wang Y; Chi J; Sun W
    Int J Oncol; 2020 May; 56(5):1284-1293. PubMed ID: 32319586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.